What is Adipotide-FTPP?
Research Focus: Weight Loss
Adipotide is a pro-apoptotic peptide that targets the blood vessels supplying white adipose tissue (fat cells). It is designed to induce programmed cell death (apoptosis) in fat cells by disrupting their blood supply.
At a Glance
Adipotide is a synthetic peptide that selectively binds to two receptors (prohibitin and ANXA2) found on the surface of blood vessels supplying white fat. This binding triggers a cascade that leads to the regression of these blood vessels. This section provides a general overview of its research context.
About Adipotide-FTPP
Adipotide is a synthetic peptide that selectively binds to two receptors (prohibitin and ANXA2) found on the surface of blood vessels supplying white fat. This binding triggers a cascade that leads to the regression of these blood vessels.
How It Works
Targeted Apoptosis
Induces programmed cell death specifically in white fat cells by cutting off their nutrient supply.
Vascular Targeting
Selectively binds to receptors on the vasculature of white adipose tissue, minimizing effects on other tissues.
Current Research Insights
Novel Mechanism
Its unique mechanism of targeting fat vasculature is highly researched as a potential method for reducing visceral fat, which is strongly linked to metabolic disease.
Areas of Study
Obesity and Visceral Fat Reduction
Investigated for its ability to reduce body weight and specifically target dangerous visceral fat.
Metabolic Health
Studied for improving insulin sensitivity secondary to fat loss.
Adipotide-FTPP is strictly intended for laboratory and clinical research:
- Available exclusively from authorized research suppliers
- Not FDA-approved for general therapeutic use
- Comprehensive safety, efficacy, and dosage guidelines remain under ongoing investigation
FAQs
Research
- Clinical and preclinical studies on pro-apoptotic peptides and adipose tissue targeting.
- Research on the role of prohibitin and ANXA2 receptors in fat vasculature.
(The above references are representative and support the research context of this peptide, GLP hormone or regenerative therapy. All claims are for research purposes only and do not imply approved medical use.)